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Abstract
Brown adipose tissue (BAT) dysfunction in aging and obesity has been related to 
chronic unresolved inflammation, which could be mediated by an impaired pro-
duction of specialized proresolving lipid mediators (SPMs), such as Lipoxins- LXs, 
Resolvins- Rvs, Protectins- PDs, and Maresins- MaRs. Our aim was to characterize the 
changes in BAT SPMs signatures and their association with BAT dysfunction during 
aging, especially under obesogenic conditions, and their modulation by a docosahex-
aenoic acid (DHA)- rich diet. Lipidomic, functional, and molecular studies were per-
formed in BAT of 2- and 18- month- old lean (CT) female mice and in 18- month- old 
diet- induced obese (DIO) mice fed with a high- fat diet (HFD), or a DHA- enriched 
HFD. Aging downregulated Prdm16 and UCP1 levels, especially in DIO mice, 
while DHA partially restored them. Arachidonic acid (AA)- derived LXs and DHA- 
derived MaRs and PDs were the most abundant SPMs in BAT of young CT mice. 
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1 |  INTRODUCTION
Brown adipose tissue (BAT) is a thermogenic tissue that dissi-
pates energy as heat under certain stimuli, mainly through the 
uncoupling protein 1 (UCP1).1 Characterized by multilocular 
adipocytes with a high mitochondrial content, BAT also plays 
a relevant role in glucose homeostasis and triglyceride clear-
ance.2,3 In the last years, BAT has also emerged as a secretory 
organ that produces batokines which can influence the activity 
of other metabolic organs.4 Growing evidence supports that BAT 
mass/activity negatively correlates with BMI, total and visceral 
adipose tissue, fasting glucose levels, and insulin resistance in 
rodents and humans.5- 9 Therefore, BAT activation has been pro-
posed as a target for the treatment of obesity and related meta-
bolic disorders, including type 2 diabetes and dyslipidaemias.10
However, BAT activity is gradually lost during the aging 
process8,11 and accordingly, the percentage of adults showing 
detectable BAT decreases with age.12 The reduced BAT ac-
tivation that occurs in aging could favor fat accumulation in 
older individuals.12 Therefore, one of the current challenges 
is to characterize the mechanisms leading to the age- induced 
reduction of BAT activity, and to discover effective strategies 
to prevent BAT loss or to reactivate existing BAT depots.13
Inflammation seems to be a key process underlying both 
physiological and pathological processes of aging and obe-
sity.14 Indeed, both obesity and aging have been identified 
as chronic, low- grade inflammatory processes. Normal aging 
leads to a more pro- inflammatory profile that is further ac-
centuated by increased adiposity.15 White adipose tissue 
(WAT) dysfunction, characterized by increased expression 
of pro- inflammatory mediators including interleukin (IL)- 1β, 
IL- 6, tumor necrosis factor- α (TNF- α), and cyclooxygen-
ase- 2 (COX- 2), and downregulation of the anti- inflammatory 
peroxisome proliferator- activated receptor γ (PPAR- γ) and 
adiponectin, contributes to the development of the systemic 
inflammatory state during aging16 and obesity.17 In fact, the 
concept of “Adipaging” has been proposed, as aging and 
obesity share inflammation and other biological hallmarks 
related to a dysfunctional adipose tissue.17
Interestingly, BAT seems to be less susceptible to de-
velop local inflammation in response to obesity than WAT.18 
However, strong/chronic pro- inflammatory signals can im-
pair BAT insulin sensitivity and affect its glucose uptake, 
which is in turn essential for BAT function.1 Moreover, 
UCP1- mediated cold- induced thermogenesis is severely 
impaired in inflamed BAT from diet- induced obese (DIO) 
mice,19 and inflammation seems to inhibit the sympathetic 
tone in BAT through mechanisms yet to be elucidated.1
In this context, resolution of inflammation is an active pro-
cess which involves the production of specialized proresolv-
ing lipid mediators (SPMs) such as lipoxins (LXs), resolvins 
(Rvs), protectins (PDs), and maresins (MaRs). Noteworthy, 
SPMs are decreased in aging in human studies,20,21 and the 
time required for the resolution of inflammation is increased in 
aged mice.22 Moreover, it has been shown that WAT of obese 
mice exhibits an impaired production of some SPMs,23,24 an 
event that constitutes one of the earliest alterations in diet- 
induced inflammation.24 Interestingly, treatment with some 
of these SPMs (RvD1 and MaR1) or precursors (17- HDHA) 
reduces WAT inflammation, improves insulin signaling and 
systemic insulin sensitivity, as well as reduces fatty liver.24- 27
With this regard, a lipidomic study has revealed a dra-
matic switch in BAT lipidome toward a WAT- like lipidome 
after a high- fat feeding period of 20  weeks.28 Regarding 
SPMs, a recent study has described Lipoxin A4 (LXA4) 
and SPMs precursors 18- HEPE, 17- HDHA, and 15- HETE 
among the main contributors to differentiate BAT from 
WAT fatty acid metabolomic phenotype.29 However, studies 
characterizing changes in SPMs levels in BAT during aging 
and obesity are lacking in the current literature. n- 3 poly-
unsaturated fatty acids (n- 3 PUFA) eicosapentaenoic acid 
(EPA), and docosahexaenoic acid (DHA) serve as substrates 
for SPMs (Rvs, PDs, and MaRs). Thus, dietary enrichment 
with n- 3 PUFA leads to an increase in SPMs production in 
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jointly funded by the Wellcome Trust and 
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Interestingly, the sum of LXs and of PDs were significantly lower in aged DIO mice 
compared to young CT mice. Some of the SPMs most significantly reduced in obese- 
aged mice included LXB4, MaR2, 4S,14S- diHDHA, 10S,17S- diHDHA (a.k.a. PDX), 
and RvD6. In contrast, DHA increased DHA- derived SPMs, without modifying LXs. 
However, MicroPET studies showed that DHA was not able to counteract the im-
paired cold exposure response in BAT of obese- aged mice. Our data suggest that a 
defective SPMs production could underlie the decrease of BAT activity observed in 
obese- aged mice, and highlight the relevance to further characterize the physiological 
role and therapeutic potential of specific SPMs on BAT development and function.
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several tissues, including WAT in rodents and humans.24,30- 33 
Furthermore, several studies in cultured adipocytes and in 
animal models have proposed n- 3 PUFA as novel inducers 
of BAT activity through the stimulation of UCP1, PR domain 
containing 16 (PRDM16), peroxisome proliferator- activated 
receptors (PPARs), peroxisome proliferator- activated recep-
tor γ co- activator 1 α (PGC1α), G protein- coupled receptor 
120 (GPR120), and fibroblast growth factor 21 (FGF21).34- 37
Based in these previous observations, our hypothesis is 
that the decay in BAT activity that occurs during aging and 
obesity could be the result of an impaired production of SPMs 
in this thermogenic tissue. Because n- 3 PUFA serve as sub-
strates for the synthesis of SPMs, we propose that long- term 
dietary supplementation with n- 3 PUFA could restore SPMs 
levels and prevent the alterations in BAT function associated 
to obesity and aging. Therefore, the aim of this study was to 
characterize the changes in BAT SPMs signatures in young 
(2  months old) and aged (18  months old) female mice, as 
well as their potential associations with BAT function mark-
ers, especially in obesogenic conditions and under long- term 
supplementation with a DHA- enriched diet.
2 |  MATERIALS AND METHODS
2.1 | Animal study design
Seven- week- old female C57BL/6J mice were purchased from 
Harlan Laboratories (Barcelona, Spain) and housed at the ani-
mal facilities of the University of Navarra under controlled 
conditions (22 ± 2°C, 12- hour light/12- hour dark cycle; rela-
tive humidity 55%  ±  10%). The animal experimental design 
is available at Figure  1. After 10- days acclimation, 15 ani-
mals (young CT, 2  months old) were sacrificed. Next, mice 
were divided into two experimental groups: a control group 
(aged CT, 18 months old, n = 14) fed a standard control diet 
up to 18 months of age (20% proteins, 67% carbohydrates, and 
13% lipids; Harlan Teklad Global Diets, Harlan Laboratories, 
Indianapolis, IN, USA); and a diet- induced obese (DIO) group 
fed with a high- fat saturated diet (High- fat diet, HFD, 20% 
proteins, 35% carbohydrates, and 45% lipids; Research Diets 
Inc, New Brunswick, NJ, USA) for 4 months. Afterward, the 
6- month- old DIO group was divided into two experimental 
groups: one continued with the HFD during 12 months (aged 
DIO, 18  months old, n  =  15); and the DIO+omega- 3 (aged 
DIOMEG, 18 months old, n = 11) that was fed for 12 months 
with the HFD supplemented with a high DHA fish oil concen-
trate (SOLUTEX0063TG, containing 683.4  mg DHA/g and 
46.7 mg EPA/g, with a total content of 838.9 mg of n- 3 PUFA/g 
as triglycerides, provided by Solutex, Spain), replacing 15% 
w/w of dietary lipids (Research Diets Inc, New Brunswick, NJ, 
USA). Because the DHA- rich n- 3 PUFA concentrate contained 
2  mg/g of mixed tocopherols (Covi- ox T- 70EU) to preserve 
from n- 3 PUFA oxidation, the same amount was added to the 
HFD of the DIO mice that continued with the standard high- fat 
feeding during this experimental period (from 6 to 18 months). 
The different HFDs (prepared by Research Diets Inc) were 
vacuum sealed in 2.5 kg plastic bags and kept frozen (−20°C) 
until used to avoid rancidity. Specific dietary compositions can 
be found in a recent manuscript of our group.38
F I G U R E  1  Animal experimental design. After 10 days of acclimation, 2- month- old (young CT) mice were sacrificed. The rest of mice were 
divided into two groups, one fed with a standard diet (CT) and other fed with a high- fat diet (HFD) for 4 months to induce obesity (DIO). These 
6- month- old DIO mice were divided into two subgroups and aged up to 18 months: the aged DIO group was fed with the HFD* and the aged 
DIOMEG group was fed with a DHA- enriched HFD. The HFD* (from 6 to 18 months) was formulated with the same amount of tocopherol mix 
contained in the DHA- enriched HFD to preserve from oxidation. An aged CT group fed with the standard diet up to 18 months was also included. 
Body composition was determined in young CT and aged (CT, DIO and DIOMEG) groups. Serum and adipose tissue samples were also collected, 
and BAT was characterized (by morphological, gene and protein expression, and lipidomic analysis). BAT activity was evaluated by MicroPET 
analysis
4 of 19 |   FÉLIX- SORIANO et AL.
All experimental groups were fed ad libitum. Animals 
were controlled for weight and food intake 3  days/week 
during the whole experiment. At 2 and 18  months of age, 
animals underwent body composition analyses. After an 
overnight fast, fat depots (interscapular BAT, subcutaneous 
inguinal, mesenteric, gonadal, and retroperitoneal WAT) 
were collected, weighted, and frozen at −80°C. Total WAT 
weight was estimated as the weight sum of inguinal, gonadal, 
retroperitoneal, and mesenteric white fat depots. BAT sam-
ples for histological analysis were also obtained, and frozen 
BAT samples were used for lipidomic, protein, and gene ex-
pression analyses. Blood samples were collected, and serum 
was obtained and frozen at −80°C for biochemical determi-
nations. At 2 and 18 months of age, a subset of five animals 
per group underwent MicroPET imaging analyses for in vivo 
BAT activity determination.
The study was designed in female mice since sex- dependent 
inactivation of thermogenesis in BAT has been proposed as one 
of the mechanisms favoring fat accumulation, and underlying 
the higher propensity for obesity under hypercaloric condi-
tions in female rats as compared to males.39 Moreover, BAT 
thermogenic activity was found to be depressed in female rats 
during caloric restriction as compared to males.40 Furthermore, 
a reduced norepinephrine turnover rate in cold- induced ther-
mogenesis has also been described in older female rats, but not 
in male,41 suggesting a more impaired thermogenic response to 
diet and in aging in female than in male rodents.
All experiments were performed according to national 
animal care guidelines, with the approval of the Ethics 
Committee for Animal Experimentation of the University 
of Navarra (protocol no. 113- 15) in accordance with the EU 
Directive 2010/63/EU.
2.2 | Body composition analyses
Before the sacrifice, whole- animal body composition was 
measured in live conscious animals with nuclear resonance 
technology (EchoMRI- 100- 700; Echo Medical Systems, 
Houston, TX, USA) as previously described.42
2.3 | Biochemical analysis
Serum biochemical analyses were performed after a 12 hours 
fasting period. Glucose, total cholesterol (total chol), HDL- 
cholesterol (HDL- chol), triglycerides, and β- hydroxybutyrate 
serum levels were determined using a Pentra C200 auto ana-
lyzer (HORIBA ABX, Madrid, Spain), following the manu-
facturer's instructions. LDL- cholesterol (LDL- chol) values 
were calculated using the Friedewald equation (LDL cho-
lesterol  =  Total- cholesterol  −  HDL- cholesterol  −  TG/5). 
Insulin levels were determined with a commercially available 
ELISA kit (Mercodia, Uppsala, Sweden), according to the 
supplier's guidelines.
2.4 | In vivo BAT activity by micro- positron 
emission tomography (MicroPET) assay
In vivo BAT activity was estimated by MicroPET imaging 
using the glucose analog [18F]Fluoro- 2- deoxy- 2- d- glucose 
([18F]FDG). Studies were performed in a small animal 
Philips Mosaic tomograph (Cleveland, OH, USA) at the 
MicroPET Unit of Clínica Universidad de Navarra.43 On the 
day of each PET study, mice were pre- exposed to cold stimu-
lation for 1 hour. [18F]FDG (10.1 ± 0.9 MBq) was injected 
through the tail vein 1 hour before PET scanning. Mice were 
under anesthesia throughout the PET acquisition procedure. 
For the assessment of [18F]FDG uptake, all studies were 
exported and analyzed using the PMOD software (PMOD 
Technologies Ltd., Adliswil, Switzerland). Images were ex-
pressed in standardized uptake value (SUV) units, using the 
formula SUV = [tissue activity concentration (Bq/cm3)/in-
jected dose (Bq)] × body weight (g). For semi- quantitative 
analysis, [18F]FDG uptake by BAT was evaluated drawing 
volume- of- interest (VOIs) on coronal PET images including 
the interscapular BAT. From each VOI, maximum voxel in-
tensity within the VOI (SUVmax) was recorded.
Ex vivo quantification of [18F]FDG uptake in BAT depots 
was also measured. For this purpose, interscapular BAT de-
pots were extracted immediately after PET imaging. Tissues 
were weighed and measured for [18F]FDG activity on a high- 
energy γ counter. Uptake levels were expressed as percentage 
of injected dose per gram of tissue.
2.5 | Histological analysis of BAT
BAT samples of the four experimental groups were fixed in 
3.7%- 4.0% neutral formalin (pH 7.4) for 24 hours, dehydrated 
with 70% ethanol, and embedded in paraffin. Five micrometers 
sections were deparaffinized and stained with hematoxylin- 
eosin (H&E). BAT images (magnification 40×) were taken 
with an Olympus inverted microscope (CKX31SF, Olympus 
Corp., Tokyo, Japan) coupled to an Olympus C- 5060 WIDE 
ZOOM digital compact camera (Olympus Corp.). Mean lipid 
droplet surface in BAT H&E- stained samples was quanti-
fied with ImageJ 2.0 imaging suite (US National Institutes of 
Health, Bethesda, MD, USA).
2.6 | BAT lipid mediator profiling
All samples were extracted using solid- phase extrac-
tion columns as previously described.44,45 Prior to sample 
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extraction, deuterated internal standards, representing each 
region in the chromatographic analysis (500 pg each) were 
added to facilitate quantification in 1  mL of methanol. 
Samples were kept at −20°C for a minimum of 45  min-
utes to allow protein precipitation. Supernatants were 
subjected to solid- phase extraction, methyl formate and 
methanol fractions were collected, brought to dryness, and 
suspended in phase (methanol/water, 1:1, vol/vol) for in-
jection on a Shimadzu LC- 20CE HPLC and a Shimadzu 
SIL- 20AC autoinjector (Shimadzu Corp., Kyoto, Japan), 
paired with a QTrap 6500+ (Sciex, Warrington, UK). For 
identification and quantitation of products eluted in the 
methyl formate an Agilent Poroshell 120 EC- C18 column 
(100 mm × 4.6 mm × 2.7 µm, Agilent Technologies, Santa 
Clara, CA, USA) was kept at 50°C and mediators eluted using 
a mobile phase consisting of methanol- water- acetic acid of 
20:80:0.01 (vol/vol/vol) that was ramped to 50:50:0.01 (vol/
vol/vol) over 0.5 minutes and then, to 80:20:0.01 (vol/vol/
vol) from 2 minutes to 11 minutes, maintained till 14.5 min-
utes and then, rapidly ramped to 98:2:0.01 (vol/vol/vol) for 
the next 0.1 minutes. This was subsequently maintained at 
98:2:0.01 (vol/vol/vol) for 5.4  minutes, and the flow rate 
was maintained at 0.5 mL/min. QTrap 6500+ was operated 
using a multiple reaction monitoring method coupled with 
information- dependent acquisition and enhanced produc-
tion scan. In the analysis of peptide- lipid- conjugated me-
diators eluted in the methanol fraction, Agilent Poroshell 
120 EC- C18 column (100 mm × 4.6 mm × 2.7 µm, Agilent 
Technologies) was kept at 50°C and mediators were eluted 
using a mobile phase consisting of methanol- water- acetic 
acid at 55:45:0.1 (vol:vol:vol) over 5  minutes, that was 
ramped to 80:20:0.1 (vol:vol:vol) for 2  minutes, main-
tained at 80:20:0.1 (vol:vol:vol) for the next 3 minutes, and 
ramped to 98:2:0.1 (vol:vol:vol) over 3 minutes. This was 
kept at 98:2:0.1 (vol:vol:vol) for 3 minutes. A flow rate of 
0.60 mL/min was used throughout the experiment. QTrap 
6500+ was operated in positive ionization mode using mul-
tiple reaction monitoring (MRM) coupled with information- 
dependent acquisition and enhanced production scan. Each 
LM was identified using established criteria, including 
matching retention time to synthetic and authentic materials 
and at least six diagnostic ions. Calibration curves were ob-
tained for each using synthetic compound mixtures at 0.78, 
1.56,3.12, 6.25, 12.5, 25, 50, 100, and 200 pg that gave lin-
ear calibration curves with an r2 values of 0.98- 0.99.46
2.7 | Protein isolation and Western 
Blot analyses
BAT samples were homogenized by sonication (SONOPULS 
Ultrasonic homogenizer HD 3100, Bandelin, Berlin, 
Germany) two times for 10  seconds each in 200  µL lysis 
buffer (8 mmol/L NaH2PO4, 42 mmol/L Na2HPO4, 1% so-
dium dodecyl sulfate (SDS), 0.1  mol/L NaCl, 0.1% NP40, 
1 mmol/L NaF, 10 mmol/L sodium orthovanadate, 2 mmol/L 
phenylmethylsulfonyl fluoride (PMSF), 10  mM ethylen-
ediaminetetraacetic acid (EDTA), and 1% protease inhibitor 
cocktail 1 (Millipore Sigma, St. Louis, MO, USA)). Then, 
samples were centrifuged at 13 000  rpm for 15 minutes to 
obtain the supernatant fraction containing the proteins. The 
protein extracts were quantified with the BCA protein assay 
kit (Thermo Fisher Scientific, Waltham, MA, USA) to deter-
mine their concentration.47
Protein extracts (15- 20 µg) were resolved by electropho-
resis on 12% SDS- polyacrylamide gels and then, electroblot-
ted onto a polyvinylidene difluoride membrane (Hybond P; 
GE Healthcare, Chicago, Ill., USA), which was blocked in 
TBS- Tween 1X buffer (TBS- T 1X) with 10% of milk (Nestle, 
Switzerland) for 1 hour at room temperature. Then, primary 
antibody anti- UCP1 (rabbit, Abcam, Cambridge, UK), was 
used at 1:1000 overnight at 4°C. After incubation, goat anti- 
rabbit IgG peroxidase- conjugated (HRP) secondary antibody 
(Cell Signaling Technology, MA, USA) was used at 1:10 000 
for 1 hour at room temperature. The immunoreactive proteins 
were detected with enhanced chemiluminescence (Thermo 
Fisher Scientific) and quantified by densitometry analysis 
(LI- COR Biosciences, Lincoln, NE, USA). The results are 
expressed in relation to the young CT group value, which was 
set to 100%.
2.8 | Gene expression by qRT- PCR
Total RNA from BAT depots was extracted with QIAzol 
Lysis reagent (Qiagen, Hilden, Germany). After quality and 
concentrations were measured (Nanodrop Spectrophotometer 
ND1000, Thermo Fisher Scientific), RNA (2 µg) was incubated 
with DNase I (Life Technologies, Carlsbad, CA, USA) for 
30 minutes at 37°C. Retrotranscription to cDNA was performed 
using High- Capacity cDNA Reverse Transcription (Applied 
Biosystems, Foster City, CA). Real- time PCR was performed 
using the Touch Real- Time PCR System (C1000 + CFX384, 
BIO- RAD, Hercules, CA, USA). Gene expression was analyzed 
using Power SYBR Green PCR (Bio- Rad, München, Germany). 
Primer- Blast software (National Center for Biotechnology 
Information, Bethesda, MD, USA (https://www.ncbi.nlm.nih.
gov/tools/ prime r- blast/) was used to design the following prim-
ers: Ccl2 (forward: 5′- AGCACCAGCCAACTCTCACT- 3′; 
reverse: 5′- TCATTGGGATCATCTTGCTG- 3′), Fgf21 (for-
ward: 5′- CCTCTAGGTTTCTTTGCCAACAG- 3′, reverse: 
5′- AAGCTGCAGGCCTCAGGAT- 3′), Il10 (forward: 5′- AA 
GGCAGTGGAGCAGGTGAA- 3′, reverse: 5′- CCAGCAGA 
CTCAATACACAC- 3′), Il4 (forward: 5′- ACAGGAGAAGG 
GACGCCAT- 3′, reverse: 5′- GAAGCCCTACAGACGAGCT 
CA- 3′), Prdm16 (forward: 5′- CAGCACGGTGAAGCCAT 
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TC- 3′, reverse: 5′- GCGTGCATCCGCTTGTG- 3′), and 36b4 
(forward: 5′- CACTGGTCTAGGACCCGAGAAG- 3′, re-
verse: 5′- GGTGCCTCTGGAGATTTTCG- 3′). Relative gene 
expression was determined by the 2−ΔΔCT method48 after inter-
nal normalization to 36b4.
2.9 | Statistical analysis
Statistical analyses were performed using one- way ANOVA 
or Kruskal- Wallis test followed by post hoc test for multi-
ple groups comparisons, and unpaired Student's t or Mann- 
Whitney's U test for direct comparisons between two groups 
after testing the normality with the Kolmogorov- Smirnov and 
Shapiro- Wilk tests. GraphPad Prism 9 software (La Jolla, CA, 
USA) and Stata 14 (Stata, Collage Station, TX, USA) were used 
for statistical analysis. Results were expressed as mean ± SEM 
and differences were considered significant at a P value < .05.
For lipid mediator analyses by PLSDA, its Scores Plot and 
VIP Scores, as well as the heatmap of lipid mediator's distri-
bution across the four experimental groups and the Pearson's 
correlations with BAT genes, MetaboAnalyst 4.0 (University 
of Alberta, Edmonton, AB, Canada) was used.
3 |  RESULTS
3.1 | Body composition, fat depots weight, 
and serum biomarkers of glucose and lipid 
metabolism
Table  1 shows body composition data and serum glucose 
and lipid metabolism biomarkers of young (2  months old) 
and aged (18 months old) mice fed with a control diet (CT) 
or a HFD without (DIO) or with DHA (DIOMEG). As ex-
pected, the aged CT mice exhibited increased body weight,47 
fat mass, as well as hyperglycemia and higher levels of total 
and LDL- chol as compared to young CT mice. The meta-
bolic changes that occurred during aging were aggravated in 
the aged DIO mice, which accumulated more fat and exhib-
ited a worsened hyperglycemia, hyperinsulinemia, and dys-
lipidemia (Table 1). Chronic feeding with the DHA- rich diet 
(aged DIOMEG group) tended to reduce body weight38,47 
and fat accumulation especially in the white adipose depots, 
in parallel with improved total chol, LDL- chol, and the ath-
erogenic index LDL- chol/HDL- chol compared to the aged 
DIO group, without significantly affecting fasting glucose 
and insulin levels (Table  1). Thus, long- term feeding with 
a DHA- enriched HFD improved lipid serum profile as com-
pared to aged DIO animals but had no significant effects on 
body composition and glucose metabolism biomarkers as 
compared to aged DIO mice.
3.2 | Aging- induced morphological, 
transcriptomic, and functional changes in 
BAT of lean, obese, and DHA- supplemented 
obese mice
In order to study the effects of aging and obesity and the long- 
term DHA supplementation on BAT biology, the changes on 
BAT morphology and on the expression of genes/proteins 
related to BAT development, function, and inflammatory 
status were investigated. Aging- induced lipid accumula-
tion also in brown adipocytes, as revealed by the increased 
weight and the histological images of BAT depots in young 
vs aged CT mice. A dramatic BAT hypertrophy accompanied 
by the appearance of unilocular adipocytes was observed in 
the aged DIO group, which was partly attenuated in the aged 
DIOMEG group, although no significant differences were 
reached neither in BAT weight nor in adipocyte lipid droplets 
size (Table 1, Figure 2A, Figure S1).
We further evaluated if the hypertrophy of BAT associ-
ated to obesity and aging occurred alongside with an altered 
expression of genes and proteins related to BAT development 
and function. Our data show that the levels of UCP1, the 
main responsible of BAT thermogenesis, was significantly 
reduced in aged CT as compared to young CT mice. Such 
reduction tended to be more pronounced in aged DIO mice. 
Noteworthy, the HFD supplementation with DHA restored 
UCP1 expression in BAT of aged obese mice (Figure 2B). A 
similar pattern was observed for Prdm16, which is required 
for the maintenance and function of brown adipocytes in 
adult mice.49 Indeed, Prdm16 mRNA expression was reduced 
with aging and worsened by obesity, but partially recovered 
in the aged DIOMEG group (Figure  2C). Moreover, fibro-
blast growth factor 21 (Fgf21), which has been also related 
to brown fat activation,36 was decreased with aging in BAT 
of aged CT mice but increased in BAT of aged DIO mice. 
Increased FGF21 has been related to resistance to its action 
and as a mechanism to counteract the increased inflammatory/
oxidative stress state associated to obesity.50 Interestingly, 
Fgf21 mRNA levels were normalized in the aged DIO mice 
fed with the DHA- enriched diet (Figure  2C). In line with 
this result, the mRNA levels of the pro- inflammatory marker 
Ccl2 (encoding for macrophage chemoattractant protein 
1, MCP- 1) were increased by aging (aged CT) and further 
augmented by obesity (aged DIO), but normalized to those 
of the aged CT mice with the DHA treatment in the aged 
DIOMEG group. In contrast, the levels of Il4, which induces 
M2 macrophages polarization,51 were decreased in the aged 
DIO group as compared with age- matched CT mice, but di-
etary DHA was not able to rescue this drop in Il4 mRNA 
levels (Figure  2C). Strikingly, an upregulation of the anti- 
inflammatory cytokine Il10 was observed during aging and 
especially in obese mice, which was reversed in the obese 
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mice receiving the DHA- supplemented diet (Figure  2C). 
Taken together, all these data suggest that DHA was able to 
reverse the detrimental gene and protein expression pattern in 
BAT induced by aging and further worsened by obesity, even 
in the absence of major morphological changes.
3.3 | Effects of aging, 
obesity, and DHA- supplementation on BAT 
lipid mediators' signature
Because lipid mediators have been considered as key regu-
lators of BAT function,52,53 we next aimed to characterize 
the lipid mediator signature of BAT in young and aged mice 
as well as the changes induced by long- term feeding with 
saturated fat or n- 3 PUFA- enriched fat. Lipid mediator pro-
filing of the n- 3 Docosapentaenoic Acid (DPA), EPA, DHA, 
and Arachidonic acid (AA)- derived bioactive metabolomes 
demonstrated that the AA- derived LXs are the most abundant 
SPMs, followed by DHA- derived MaRs and PDs, in BAT 
of young female mice housed at 22°C (Figure 3). Figure S2 
shows a heatmap of all lipid mediators analyzed, as well as 
the sum of each lipid mediator's classes in the young and 
aged lean (CT), aged obese (DIO), and aged obese+DHA 
(DIOMEG) groups. Figure  4A shows the PLSDA analysis 
of lipid mediators' concentrations in BAT of the four experi-
mental groups. Colored ellipse areas display the 95% confi-
dence region. As shown by the Scores Plot, the young and 
aged CT groups shared more similarities in lipid mediators' 
distribution than the aged DIO group, suggesting that the dif-
ferences in lipid mediators induced by aging were aggravated 
by the diet- induced obesity. Moreover, the aged DIOMEG 
group was clearly differentiated from the rest of the groups, 
despite being fed with a diet providing the same fat amount 
but partially replaced by a high DHA n- 3 PUFA concentrate. 
Moreover, the PLSDA VIP scores revealed that mediators 
from the Rvs and MaRs families were predominant among 
the main 15 mediators contributing to such differences be-
tween groups (Figure 4B). Furthermore, the analyses of the 
total SPMs abundance between the four experimental groups 
showed that the aged DIO group displayed significantly 
lower SPMs levels when compared to the young CT group. 
Noteworthy, n- 3 PUFA supplementation was able to signif-
icantly increase SPMs levels in the DIOMEG group com-
pared not only to the aged CT and DIO groups, but also to the 
young CT group (Figure 4C).
We further aimed to characterize the contribution of the 
n- 3 DPA, DHA, EPA, and AA- derived SPMs to the observed 
effects in BAT of the obese- aged mice and after the long- term 
feeding with the DHA- enriched HFD. Interestingly, only the 
sum of PDs and LXs was significantly lower in the aged DIO 
group than in the young CT group (Figure 4D). The reduction 
in LXs levels found in the DIO- aged mice compared to CT 
young mice did not improve with n- 3 PUFA supplementation, 
likely because LXs are produced from AA. In contrast, the 
sum of each n- 3 DPA, DHA, and EPA- derived SPMs classes 
was significantly elevated in those mice fed with the DHA- 
rich HFD, reaching levels significantly higher than those 
T A B L E  1  Effects of aging on body composition, white and brown adipose tissue weights, and serum biomarkers of glucose and lipid 
metabolism in young and aged lean (CT) and aged obese mice fed with a diet rich in saturated fat (DIO) or a diet enriched in DHA (DIOMEG)
Young Aged
CT CT DIO DIOMEG
Fat mass (%) 13.19 ± 0.59 29.82 ± 1.89*** 53.44 ± 1.69***,### 50.45 ± 1.35***,### 
BAT (g) 0.06 ± 0.00 0.09 ± 0.01*** 0.26 ± 0.03***,### 0.20 ± 0.01***,### 
WAT (g) 0.40 ± 0.03 1.79 ± 0.19*** 8.15 ± 0.81***,### 5.66 ± 0.16**,# 
Triglycerides (mg/dL) 52.50 ± 6.70 58.29 ± 3.26 66.67 ± 3.94 61.50 ± 6.25
Total chol (mg/dL) 66.75 ± 4.85 98.86 ± 7.05* 134.78 ± 7.33**,## 90.75 ± 9.72‡ 
LDL- chol (mg/dL) 21.95 ± 3.42 38.65 ± 3.72* 67.48 ± 5.07**,## 27.06 ± 3.76‡‡ 
HDL- chol (mg/dL) 34.30 ± 2.54 48.55 ± 3.37* 53.93 ± 3.04** 51.39 ± 5.46
LDL- chol/HDL- chol 0.64 ± 0.08 0.79 ± 0.03 1.25 ± 0.07**,### 0.52 ± 0.03##,‡‡ 
β- Hydroxybutyrate (mmol/L) 1.53 ± 0.34 1.31 ± 0.15 1.32 ± 0.11 1.35 ± 0.31
Glucose (mmol/L) 4.89 ± 0.64 5.84 ± 0.49* 7.61 ± 0.50**,# 7.79 ± 0.68**,# 
Insulin (mU/L) 2.99 ± 0.21 2.90 ± 0.06 4.43 ± 0.33*,### 3.61 ± 0.32# 
Note: Data are expressed as mean ± SEM. Fat mass (%) corresponds to body composition analysis performed in non- fasted mice. BAT and WAT weights and 
biochemical analysis are from overnight fasted mice. (n = 5- 10).
*P < .05; **P < .01; ***P < .001 vs young CT group.
#P < .05; ##P < .01; ###P < .001 vs aged CT group.
‡P< .05; ‡‡P < .01 vs aged DIO group.
8 of 19 |   FÉLIX- SORIANO et AL.
F I G U R E  2  Differential effects of aging on BAT morphology, gene, and protein expression in young and aged lean (CT), as well as in 
obese female mice chronically fed with a HFD rich in saturated fat (DIO) or with a DHA- enriched HFD (DIOMEG) at 18 months of age. A, 
Representative BAT histology images. B, UCP1 protein levels in BAT of young vs aged control mice (CT, left panel) and in BAT of aged CT, 
DIO, and DIOMEG mice (right panel). Representative western blot (top panel) and densitometry analysis (bottom panel) of UCP1. Band densities 
of UCP1 were normalized to β- actin. C, mRNA levels of genes involved in BAT development, function, and inflammation. Data are expressed 
as mean ± SEM. (n = 5- 10). *P < .05, **P < .01, ***P < .001 vs young CT group; #P < .05, ##P < .01, ###P < .001 vs aged CT group; ‡P < .05, 
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found even in young CT mice (Figure  4D). Our next step 
was to analyze the changes in individual n- 3 DPA, DHA, and 
EPA- derived lipid mediators, to identify those with most rel-
evance/contribution to the reduced levels of SPMs observed 
in aged obese animals and those that were most markedly 
stimulated by n- 3 PUFA supplementation. Among them, 
MaR2 and 4S,14S- diHDHA (Figure 5A), 10S,17S- diHDHA, 
17R- PD1, PD2n- 3 DPA and 10S,17S- diHDPA (Figure 5B), and 
F I G U R E  3  Abundance of AA, DHA, 
n- 3 DPA, and EPA- derived specialized 
proresolving lipid mediators (SPMs) in BAT 
from young female mice (2 months of age). 
(n = 5). ***P < .001 vs LXs; #P < .05, 
##P < .01 vs MaRs
F I G U R E  4  Changes in BAT lipid mediators profile induced by aging, obesity, and dietary DHA supplementation. A, PLSDA analysis of lipid 
mediator concentrations in BAT of the four experimental groups. Colored spherical areas display the 95% confidence region. B, Vip Scores of the 
15 lipid mediators contributing more to the separation between groups in the PLSDA model. C, Sum of specialized proresolving lipid mediators 
(SPMs) showing reduced levels in aged (18 months old) DIO mice but not in DIOMEG mice. D, Graph bar showing the differential distribution 
of the different types of SPMs (DHA, n- 3 DPA, EPA, and AA- derived) in the four groups of study. Data are expressed as mean ± SEM. (n = 5). 
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RvD6, RvT1, and RvD5n- 3 DPA (Figure  5C) were the most 
decreased by the combination of chronic high- fat feeding and 
aging, as revealed by the comparison of the aged DIO to the 
young CT group. More information concerning the changes 
in other SPMs and lipid intermediates of the DHA and n- 3 
DPA- derived MaRs, PDs, Rvs pathways can be found in 
Figure S3A- C. It is worth mentioning that E- series Rvs con-
centrations were not affected by either age or obesity (Figure 
S3D). Concerning the changes induced by long- term supple-
mentation with the DHA- enriched diet on specific SPMs, 
our data revealed that almost all DHA and n- 3 DPA- derived 
MaRs (MaR1, MaR2, 4S,14S- diHDHA, 7S,14S- diHDHA, 
MaR2n- 3 DPA, and 7S,14S- diHDPA), PDs (PD1, 10S,17S- 
diHDHA, 17R- PD1, PD2n- 3 DPA, and 10S,17S- diHDPA), and 
Rvs (RvD1- 6, 17R- RvD3, RvT1 and RvT4, and RvD1n- 3 
DPA, RvD2n- 3 DPA, and RvD5n- 3 DPA) were higher in the aged 
DIOMEG group when compared to the aged DIO group 
(Figure 5A- C, Figure S3A- C). Regarding EPA- derived Rvs, 
RvE2 and RvE3, but not RvE1, were markedly increased in 
the aged DIOMEG group (Figure S3D). A moderate increase 
in some EPA- derived Rvs could be expected, as the DHA- 
rich n- 3 PUFA concentrate also contained a small amount 
of EPA.
The analyzed AA- derived pro- and anti- inflammatory 
lipid mediators are shown in Figure  6. Our data revealed 
a significant decrease in LXA4, LXB4, and 15- epi- LXA4 
in BAT of aged DIO mice compared to young CT mice 
(Figure  6A). Another relevant finding was the decrease in 
PGF2α observed in BAT of aged mice (both CT and DIO) 
when compared with young mice (Figure 6B). A reduction 
in LTC4 and 20- OH- LTB4 was also observed in aged DIO 
mice as compared to the young CT mice (Figure  6C). No 
other significant changes were observed in AA- derived lipid 
mediators because of aging and/or obesity. Regarding the ef-
fects of the DHA- rich HFD, PGE2 and PGF2α were decreased 
(Figure 6B), while LTC4 was increased (Figure 6C), in the 
aged DIOMEG group as compared to the aged DIO group.
In summary, aging and obesity rather than aging alone 
had lowering effects on SPMs abundance, while few pro- 
inflammatory lipid mediators were significantly affected by 
these conditions. The DHA- rich HFD reverted this decrease 
in several of the DHA, n- 3 DPA, and EPA- derived SPMs, 
without restoring the AA- derived SPMs.
3.4 | Correlations between BAT 
genes and lipidomics
With the aim to characterize the potential relationship be-
tween the levels of lipid mediators and the mRNA levels 
of genes involved in BAT development, function, and in-
flammatory status, Pearson's correlations were carried out. 
Figure 7 shows the heatmap of correlations between BAT 
genes (Prdm16, Fgf21, Ccl2, Il4, and Il10) and each lipid 
mediator/pathway marker identified, or with sums of the 
different lipid mediator's families, considering all experi-
mental groups of the study. Prdm16 gene expression posi-
tively correlated with the sum of LXs, as well as with some 
individual lipid mediators from the LXs family (LXB4, 
15- epi- LXA4, and 15- epi- LXB4). A positive correlation 
was also found with LTC4 and 5S,12S- diHETE (LTB4 
pathway marker), and with the sums of LTBs and cysLTs. 
These apparently contradictory results could be explained 
by the fact that these lipid mediators are all derived from 
F I G U R E  5  Quantification of principal changes induced by aging, obesity, and dietary DHA supplementation on BAT- specific SPMs and lipid 
intermediates of the DHA and/or n- 3 DPA- derived Maresins (MaRs, A), Protectins (PDs, B), and Resolvins (Rvs, C) pathways. Data are expressed 
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the lipoxygenase (LOX) AA- pathway. Moreover, Prdm16 
correlated with 4S,14S- diHDHA, pathway marker of the 
DHA- derived MaRs.
Regarding Fgf21, its mRNA levels negatively correlated 
with some individual AA- derived pro- inflammatory lipid 
mediators (LTC4, PGD2, and TxB2), and with the sum of 
LTBs, cysLTs, TXs, and the total of pro- inflammatory lipid 
mediators (Pro- LMs). Nevertheless, a negative correlation 
was observed for 15- epi- LXA4, 15- epi- LXB4, and for the 
sum of LXs, suggesting a role for both pro- inflammatory and 
proresolving AA- derived lipid mediators in the regulation of 
Fgf21 in BAT.
Interestingly, the gene expression levels of the pro- 
inflammatory chemokine Ccl2 (MCP- 1) negatively correlated 
with the sum of SPMs and with the sum of all Rvs and PDs 
classes (RvDs, RvEs, RvTs, RvDsn- 3DPA, PDs, and PDsn- 3DPA). 
Individual SPMs that negatively correlated with Ccl2 included 
DHA and/or n- 3 DPA- derived RvD1, RvD3, RvD5, RvD6, 
RvT1, RvT4, RvD5n- 3DPA, 10S,17S- diHDHA, 10S,17S- 
diHDPA, PD2n- 3DPA, MaR1, MaR2, 4,14- diHDHA, and 
7S,14S- diHDPA. Despite a negative correlation was also found 
with the pro- inflammatory LTC4, all these observations sug-
gest that the expression of this chemokine, which promotes the 
recruitment of M1 pro- inflammatory macrophages to adipose 
tissue, was clearly negatively related to the levels of SPMs.
Moreover, the mRNA expression of the anti- inflammatory 
cytokine Il10 was negatively correlated with the sum of Pro- 
LMs and, accordingly, with the sum of LTBs, cysLTs, PGs, 
and TXs. Individual negative correlations were found for 
5S,15S- diHETE, 5S,12S- diHETE, LTC4, PGE2, PGF2α and 
TXB2. Although no correlations were found between Il10 
and any of the individual LXs measured, a negative associa-
tion was observed for the sum of LXs, suggesting a potential 
dual role for LOX- derived lipid mediators in the modulation 
of Il10 mRNA levels, and vice versa. Despite IL- 4 functions 
as an anti- inflammatory cytokine are well established, no as-
sociations were found between any SPM and this interleukin. 
Altogether, these data suggest strong associations of the an-
alyzed lipid mediators with BAT function and inflammatory 
status, which were more significant for Prdm16, Ccl2, and 
Il10 mRNA levels.
3.5 | Effects of aging, obesity, and long- 
term DHA supplementation on cold- induced 
BAT activation
Finally, we evaluated the changes in BAT activity in re-
sponse to cold activation during aging and under obeso-
genic conditions, as well as the potential ability of DHA 
to prevent the decline in BAT activation. BAT activity in 
response to cold exposure was estimated by in vivo [18F]
FDG uptake MicroPET (Figure 8). PET analysis (coronal 
images, SUVmax value and ex vivo quantification of [18F]
FDG uptake in BAT depots)54 revealed a clear decrease in 
BAT activation with aging, which was dramatically exacer-
bated in aged, obese groups. Besides the beneficial effects 
of DHA on genes and proteins regulating BAT develop-
ment and function (Prdm16 and UCP1), chronic dietary 
supplementation with this fatty acid was not able to reverse 
the impaired BAT response to cold observed in aged DIO 
mice (Figure 8A- C).
F I G U R E  6  Characterization of changes in specific AA- derived lipid mediators involved in the Lipoxins (LXs, A), Prostaglandins and 
Thromboxanes (PGs and TXs, B) and Leukotrienes (LTs, C) pathways in BAT of female mice induced by aging, obesity, and dietary DHA 
supplementation. Data are expressed as mean ± SEM. (n = 5). *P < .05, **P < .01, ***P < .001 vs young CT group; #P < .05, ##P < .01 vs aged 
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4 |  DISCUSSION
Here, we describe for the first time BAT composition in n- 3 
PUFA- derived and AA- derived proresolving lipid mediators 
in young control mice, along with their changes during aging, 
especially in obese mice and after chronic feeding with a 
DHA- enriched HFD.
Lipid mediator profiling studies of BAT revealed that 
the most abundant SPMs in CT mice at 2 months of age 
housed at room temperature were AA- derived LXs fol-
lowed by DHA- derived MaRs and PDs. The most abun-
dant AA- derived LXs pathway included 5S,15S- diHETE, 
15- epi- LXA4, and LXB4, suggesting a potential role of 
these lipid mediators in the active BAT. A recent study has 
shown that LXA4 and its precursor 15- HETE are among 
the major contributors differentiating BAT from WAT 
under thermoneutrality conditions.29 Moreover, a study 
has suggested the relevance of the LXs pathway in BAT 
activity. Indeed, the overexpression of the arachidonate 
5- lipoxygenase- activating protein (ALOX5AP), which is 
involved in the biosynthesis of LXs, increased LXA4 pro-
duction, upregulated UCP1, and thermogenesis resulting in 
protection against diet- induced obesity and insulin resis-
tance in mice.55 In our study, LXA4 was also identified in 
BAT of young mice, but the levels were lower than those 
of LXB4 or 15- epi- LXA4, suggesting an undescribed role 
for these two AA- derived lipid mediators in BAT function. 
Interestingly, the levels of 15- epi- LXA4, LXB4, and LXA4 
were significantly decreased in BAT of aged DIO mice, in 
parallel with the dramatic drop in BAT activity as revealed 
by the lower UCP1 levels and especially the [18F]FDG 
uptake by this tissue. LXs were shown to be decreased in 
WAT from aging animals which also showed decreased res-
olution of inflammation.22 Moreover, a study has shown 
that aging is accompanied by a profound decrease in LXA4 
urine levels, especially from middle- aged adulthood to 
older adults.21
Concerning AA- derived lipid mediators, our study has 
also found that AA- derived prostaglandins (PGs: PGD2, 
PGE2 and PGF2α) constitute the most abundant analyzed lipid 
mediators in BAT of young mice. In addition to their role in 
inflammation, AA- derived PGs are also involved in the regu-
lation of cell proliferation and differentiation and energy me-
tabolism.56 Indeed, a study has shown that the COX- 2- derived 
PG pathway seems to play a relevant role in controlling the 
differentiation of defined mesenchymal progenitors toward 
the phenotype of brown adipocytes.57 Moreover, PGE2 has 
been proposed to promote white- to- brown adipogenic differ-
entiation.58 In this way, the study of Garcia- Alonso et al59 
has shown that PGE2 reduced inflammatory genes (IL- 6 and 
F I G U R E  7  Heatmap showing Pearson's correlations of 
individualized lipid mediators and the sums of lipid mediator's classes 
with the expression of genes involved in BAT development, function, 
and inflammatory status (Prdm6, Fgf21, Ccl2, Il10, and Il4). Negative 
correlations are shown in blue and positive correlations are in red (see 
color scale). P value is indicated for significant correlations (P < .05)
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MCP- 1) and induced the expression of brown markers (UCP1 
and PRDM16) in WAT and adipocytes. Although PGE2 levels 
were moderately reduced during aging in BAT, no significant 
changes were observed. In contrast, our study has revealed 
that the levels of PGF2α were significantly inhibited in aged 
CT and DIO animals, suggesting that the drop in this eicosa-
noid could be involved in BAT reduced activity during aging. 
A study in humans has shown that serum 15- keto- PGF2α is 
decreased, and correlates negatively with aging in nonobese 
humans.20 However, the role for PGE2 and PGF2α on thermo-
genic adipocytes is controversial, since other study has shown 
that AA inhibits the browning process in human adipose 
tissue- derived mesenchymal stem cells (hMADS) adipocytes 
through the secretion of PGE2 and PGF2α.
60 Moreover, PGE2 
and PGF2α as well as 10S,17S- diHDHA (PDX) were also 
recently unraveled as one of the main lipid mediators that 
contribute to differentiate BAT from WAT under thermoneu-
trality conditions.29
Our study has also identified PDX as the most abundant 
DHA- derived PD in BAT of young mice that is reduced 
by aging especially in obese mice. PDX administration to 
obese diabetic mice improves insulin sensitivity by raising 
IL- 6 skeletal muscle, without any impact on adipose tissue 
inflammation.61 However, the same authors found that PDX 
is present in WAT and promotes PPAR- γ transcriptional ac-
tivity in fat1 transgenic mice.62 Our current data suggest that 
PDX could play an uncharacterized role in BAT maintenance 
during aging.
DHA- derived MaR2 and 4S,14S- diHDHA are the most 
abundant molecules of the MaRs pathways, and both are 
significantly reduced during aging mainly in obese- aged 
mice. A similar trend was observed for MaR1 which was 
F I G U R E  8  Cold- stimulated BAT activity is decreased with aging especially in obese mice, and it is not preserved by chronic DHA 
supplementation. A, BAT activity assessed by [18F]FDG MicroPET in the four experimental groups. Mice were exposed for 1 hour at 4°C, prior 
injection of [18F]FDG: coronal sections of mice. Red arrow: interscapular BAT pads. B, Maximum standardized uptake value (SUVmax/BAT 
weight (g)). C, Ex vivo quantification of [18F]FDG uptake in BAT depots. (n = 4- 5). Data are expressed as mean ± SEM. *P < .05 vs young CT 
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less abundant in BAT of young mice. MaRs, biosynthesized 
through the 12- LOX pathway, are macrophage mediators 
with potent anti- inflammatory and proresolving actions.63,64 
Previous studies from our group have demonstrated that 
MaR1 attenuates inflammation, improves insulin resistance, 
and restores metabolic pathways in adipocytes and in WAT of 
obese mice.26,65 MaR1 has been also shown to resolve aged- 
associated macrophage inflammation to improve bone re-
generation.66 However, the actions of MaR2 in brown/white 
adipose tissue are still unknown. Clària et al23 found that 14- 
HDHA, a precursor of MaRs, was reduced in WAT of obese 
mice. Interestingly, Leiria et al53 described that 14- HDHA 
was increased in BAT from female mice after 7 days of cold 
exposure compared to thermoneutrality conditions, and that 
this change occurred along with improved glucose uptake in 
BAT. This observation clearly suggests a role of the MaRs 
pathway in the regulation of BAT thermogenesis.
Although the abundance of Rvs in BAT was significantly 
lower than LXs, PDs, and MaRs, some of them showed rel-
evant changes during obesity and aging. Thus, the levels of 
RvD6 and RvT1 were significantly lower in BAT of aged 
DIO mice. To the best of our knowledge, there is no previous 
data about the identification of these Rvs in adipose tissue 
or with changes in obesity. However, a metabolome study in 
human plasma identified RvD6 as a biomarker decreased in 
the aging process.20 Although the effects of some Rvs such as 
RvD1 and RvD2 have been well characterized on the obese 
WAT,23,25,67 there is few information available about their 
effects on BAT. Interestingly, Pascoal et al68 found that the 
intracerebroventricular administration of RvD2 promotes 
UCP1 and PGC1α expression in BAT at doses of 3 ng, but 
not at 50 ng, which did not have any significant effect.
Few studies have analyzed the changes in BAT lipidomics 
during aging. A recent study using integrated metabolomics 
has found an altered lipid profile in BAT of an animal model 
of extreme longevity, the Ames dwarf mice, identifying in-
creased levels of 5- HEPE, an n- 3 PUFA metabolite, in BAT 
of these animals which exhibit increased thermogenesis.69 
This study reinforces that changes in BAT lipid signatures 
might account for the changes in BAT activity during aging.
In this sense, our study provides novel observations sup-
porting that the decrease in BAT activity that occurs with 
aging, and especially in obesogenic conditions, could be re-
lated with a decrease in the abundance of proresolving lipid 
mediators in this tissue. However, the observations that the 
decrease in SPMs was much more pronounced in aged obese 
than in aged lean mice, suggests that the HFD feeding or obe-
sity per se could be major determinants of SPMs reduction in 
BAT as compared to aging alone. Indeed, shorter periods of 
HFD- feeding or genetic obesity have been shown to reduce 
SPMs content in WAT.24 Therefore, to better discriminate 
the effects of obesity and aging on BAT SPMs signature, it 
would be of interest to determine, in future studies, if high- fat 
feeding in younger animals is able to alter the SPMs profile 
of BAT.
In this context, a recent study in human adipose tissue 
has revealed that the presence of active BAT is positively 
associated with an anti- inflammatory oxylipins/eicosanoids 
profile.70 Similarly, EPA and DHA have been recently associ-
ated with the levels of BAT activity in humans.71 A lipidomic 
analysis of BAT in young mice showed that phospholipids 
and free fatty acids were more abundant in BAT than in WAT, 
and that phospholipids in BAT were mostly composed of 
PUFAs, especially DHA.72
Our study shows that chronic dietary supplementation 
with DHA was able to reverse the drop in the sum of SPMs 
observed in BAT of aged DIO mice, reaching even values 
significantly higher than those found in BAT of young mice. 
This occurs in parallel with the upregulation of UCP1 and 
Prdm16 and with a drop of pro- inflammatory genes such as 
Ccl2 in BAT of DHA- supplemented aged DIOMEG mice. 
Several studies in cultured brown adipocytes have demon-
strated the ability of n- 3 PUFA, mainly EPA to induce brown 
development and thermogenic functions.36,73,74 Moreover, 
several studies in mice have shown that dietary supplementa-
tion with n- 3 PUFA- rich fish oil (8- 12 weeks) induce UCP1 
expression in BAT.35,74,75
Our current data suggest that DHA supplementation 
could be an approach to restore the deleterious effects of 
aging and obesity on key genes and proteins involved in 
BAT development and function, and that these DHA's ac-
tions are mediated through the increase in the production of 
all types of n- 3 PUFA- derived SPMs (PDs, MaRs, and Rvs). 
Previous studies have shown that DHA administration led 
to an increase in SPMs and oxylipins in WAT both in animal 
models of obesity24,26,32 and obese subjects.33 Such increase 
in SPMs occurred along with decreased time for resolution 
of inflammation, decreased macrophages infiltration, and 
induction of an anti- inflammatory phenotype. Our cur-
rent data also show a relationship between the changes in 
SPMs and the expression of pro- inflammatory and anti- 
inflammatory genes in BAT, suggesting a causative cor-
relation between both facts. Only two recent investigations 
analyzed the effects of n- 3 PUFA supplementation on BAT 
activity and its relation to SPMs. Colson et al76 recently 
compared the effects of 12 weeks feeding with a isocaloric 
diet enriched with n- 6 PUFA or n- 3 PUFA on oxylipin syn-
thesis and adipose tissue inflammatory markers, observing 
that diet- enrichment with n- 3 PUFAs induced an increase 
in oxylipins derived from EPA and DHA, without affect-
ing the n- 6 AA- derived metabolites. However, the levels of 
the final metabolites of oxylipins- pathway (PDX, MaR1, 
RvD1, RvD2, and RvE1) were barely or non- detected in 
this study as compared to our current data. However, DHA- 
derived LOX pathway 17- HDHA and 14- HDHA were de-
tectable and increased with the n- 3- PUFA- enriched diet. 
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In parallel, an increase in M2 macrophage markers was 
observed without changes in pro- inflammatory (Il1β, Il2, 
and Tnfa) or anti- inflammatory (Il4 and Il10) gene markers 
in BAT. Nevertheless, mice were younger (22 weeks) and 
were housed in thermoneutrality conditions (28  ±  2°C), 
without a high- fat dietary challenge and with a different di-
etary content of n- 3 PUFA. Interestingly, Ghandour et al77 
found that dietary n- 3 PUFA supplementation increased 
UCP1 in BAT and reduced the AA- derived TXB2. Our cur-
rent data also show that DHA- supplementation increased 
UCP1 in BAT and reduced TXB2 levels in aged DIO mice.
We also tested if the increase in UCP1 and Prdm16 along 
with the rise in n- 3 PUFA- derived SPMs was associated 
with an improved BAT activity in response to cold- stimuli. 
Intriguingly, the MicroPET studies revealed that the drop in 
BAT [18F]FDG uptake observed in aged DIO mice was not 
recovered by chronic DHA supplementation, suggesting that 
other mechanisms involved in the cold- induced BAT activa-
tion impaired by obesity and aging are not restored by DHA 
supplementation. Sympathetic tone plays a key role in cold- 
induced BAT thermogenesis. Indeed, denervation of BAT in 
cold- exposed animals highlights the importance of its sym-
pathetic innervation for thermogenic responses.78 Moreover, 
an altered sympathetic tone has been hypothesized as a pos-
sible cause for the decrease in BAT recruitment in aging.79 
Importantly, a study has found that reduced cold- induced 
thermogenesis correlate with norepinephrine turnover rates 
that were reduced in older female rats, but not in male.41 Our 
study has been carried out in female mice and, therefore, we 
hypothesized that the defective cold response in aged DIO 
mice could be secondary to altered sympathetic tone. In this 
way, a study showed that fish oil intake was not able to induce 
UCP1 expression in transient receptor potential vanilloid 1 
(TRPV1) knockout mice, suggesting that n- 3 PUFA could in-
duce UCP1 upregulation in BAT via the sympathetic nervous 
system.35
Another hypothesis for the lack of relevant effects on 
BAT activity beside the increase in SPMs after chronic 
DHA supplementation could be that obesity and aging might 
also impair the expression/function of SPMs receptors in 
BAT. No study has investigated this issue, but others have 
found decreased expression of the receptors ALX/FPR2, 
Chemerin Receptor 23 (ChemR23) and G protein- coupled 
receptor 32 (GPR32) in WAT depots from obese mice and 
humans compared to lean.23 Moreover, the knockout mice 
for ChemR23 and ALX/FPR2 developed obesity and, over the 
course of 12 months, cardiometabolic dysfunctions typical of 
aging.80,81 Future studies should focus in characterizing the 
changes in the expression and function of the SPMs receptors 
and SPMs signaling in BAT during aging and obesity, as they 
could also be relevant for the changes in BAT activation and 
for the efficient response to these metabolically active prore-
solving molecules.
In contrast to the rise observed for n- 3 PUFA- derived 
SPMs, DHA supplementation was not able to reverse the 
dramatic drop in LXs observed in BAT of obese- aged mice. 
Taken into account the previously described thermogenic 
properties of the LXs pathway activation in BAT,55 our data 
suggest that LXs could be important in mediating the loss of 
BAT activity during aging and the cold- response capacity in 
this tissue. Indeed, we have observed a correlation between 
Prdm16 and the sum of LXs in BAT. However, further stud-
ies are needed to test this possibility.
Furthermore, previous studies have suggested sex differ-
ences in BAT lipidomic profile.72 Moreover, differential re-
sponses in BAT proteome and function have been observed 
between male and female after dietary interventions with both 
high- fat feeding or caloric restriction.40,82,83 A limitation of 
our current study is that it has been conducted only in female 
mice. Therefore, it would be of high relevance to carry out 
further comparative studies of SPMs changes in aged obese 
male and female mice in future studies. Another interesting 
issue to be addressed in future trials is the characterization of 
the changes in SPMs in BAT under thermoneutrality and cold 
exposure conditions.
In summary, our lipid mediator profiling analysis re-
vealed for the first time that obesity promotes the decay in 
n- 3 PUFA and AA- derived SPMs that occurs during aging 
in BAT, which relates with reduced markers of BAT func-
tion. Although long- term DHA supplementation prevented 
the drop in n- 3 PUFA- derived SPMs in BAT, and improved 
BAT biomarkers, it was not able to restore the impaired re-
sponse to cold exposure observed in obese- aged mice. Our 
study highlights the relevance to carry out further research 
to better characterize the physiological role of specific 
SPMs on BAT development and function as they could be 
potential therapeutic targets to modulate this thermogenic 
tissue.
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